Biocept (BIOC) executive Taylor received 134,550 Stock Option (right to buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Darrell Taylor (executive at Biocept Inc., BIOC) reported that they received 134,550 Stock Option (right to buy) on Feb 28, 2022.
- Reporting person
- Taylor Darrell
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 28, 2022 | Grant or award (A) | Stock Option (right to buy)On 134,550 Common Stock1 | +134,550 | - | - | 134,550 direct |
Holdings before and after
- Stock Option (right to buy): 0 to 134,550 direct
Footnotes from the filing
- 1. 25% of the shares subject to the option shall vest on the first anniversary of December 28, 2021 with the balance vesting in equal monthly installments thereafter until fully vested on December 28, 2025.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Taylor report in this BIOC Form 4?
Darrell Taylor (executive at Biocept Inc., BIOC) reported that they received 134,550 Stock Option (right to buy) on Feb 28, 2022.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for BIOC
Earlier insider filings at BIOC
- Mar 3, 2022SEC Form 4 filed by Riccitelli Samuel D
- Mar 2, 2022SEC Form 4 filed by Morales Antonino
- Dec 10, 2021SEC Form 4: Hale David F sold $1,807 worth of shares (445 units at $4.06), decreasing direct ownership by 8% to 796 units
- Sep 3, 2021SEC Form 4 filed by Nall Michael W.
- Sep 3, 2021SEC Form 4 filed by Terry Michael J
Keep researching BIOC
- BIOC insider tradesEvery buy and sale reported by Biocept Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
BIOC
Biocept Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical Specialities
- Listed since
- 2014
Get push alerts for BIOC
Full BIOC profile on Quantisnow Follow BIOC and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time